Ruxolitinib

Ruxolitinib ATC Code L01EJ01 : Antineoplastic and immunomodulating agents - Antineoplastic drugs - Protein kinase inhibitors - Janus-associated kinase (JAK) inhibitors - Ruxolitinib
Ruxolitinib
Ruxolitinib
LatinRuxolitinibum
RoutesOral, topical
Pregnancy categoryC
FDA Approval Date2011-11-16
EMA Approval Date2012-08-23
Molecular FormulaC17H18N6
Molecular Weight306.36502 g/mol
CAS Number941678-49-5
Ruxolitinib 3D


ATC Codes

  1. Alimentary tract and metabolisma
  2. Blood and blood forming organs
  3. Cardiovascular system
  4. Dermatological drugs
  5. Genitourinary system and reproductive hormones
  6. Systemic hormonal preparations
  7. Antiinfectives for systemic use
  8. Antineoplastic and immunomodulating agents
  9. Musculoskeletal system
  10. Nervous system
  11. Antiparasitic products, insecticides and repellents
  12. Respiratory system
  13. Sensory organs
  14. Various ATC structures

The newly added categories

  1. Givosiran
  2. Volanesorsen
  3. Casimersen
  4. Zanubrutinib
  5. Tivozanib
  6. Fedratinib
  7. Tucatinib
  8. Everolimus
  9. Abemaciclib
  10. Selumetinib